646502-53-6 (VcMMAE,VcMMAE)

马来酰亚胺己酰基-缬氨酸-瓜氨酸-对氨基苄氧羰基单甲基奥瑞他汀E;

VcMMAE;MC-VC-PAB-MMAE;Val-cit-pab-mmae;Vc-MMAE;Maleimidocaproyl-valine-citrulline-p-aminobenzyloxycarbonyl monomethylauristatin E;4147AH;C68H105N11O15;AK187613;MC-VC-PAB-MMAE,MC-Val-Cit-PAB-MMAE;A14362;WAB50253;UNII-026S2O80A8;AKOS037643764;MALEIMIDOCAPROYL-VALINE-CITRULLINE-P-AMINOBENZYLOXYCARBONYL-MONOMETHYLAURISTATIN E;026S2O80A8;CS-0899102;CS-1242;DA-48534;SGD-1006;mc-Val-Cit-PABC-MMAE;SCHEMBL12813464;HY-15575;Q27231498;HY-15575G;MFCD25372036;GLXC-10777;AS-35255;EX-A1506;AC-32509;VEDOTIN PARENT;646502-53-6;VcMMAE (GMP);

MFCD25372036

NLMBVBUNULOTNS-HOKPPMCLSA-N

1S/C68H105N11O15/c1-15-43(8)59(51(92-13)38-55(83)78-37-23-27-50(78)61(93-14)44(9)62(85)71-45(10)60(84)47-24-18-16-19-25-47)76(11)66(89)57(41(4)5)75-65(88)58(42(6)7)77(12)68(91)94-39-46-29-31-48(32-30-46)72-63(86)49(26-22-35-70-67(69)90)73-64(87)56(40(2)3)74-52(80)28-20-17-21-36-79-53(81)33-34-54(79)82/h16,18-19,24-25,29-34,40-45,49-51,56-61,84H,15,17,20-23,26-28,35-39H2,1-14H3,(H,71,85)(H,72,86)(H,73,87)(H,74,80)(H,75,88)(H3,69,70,90)/t43-,44+,45+,49-,50-,51+,56-,57-,58-,59-,60+,61+/m0/s1

O(C([H])([H])[H])[C@]([H])([C@]([H])(C(N([H])[C@]([H])(C([H])([H])[H])[C@]([H])(C1C([H])=C([H])C([H])=C([H])C=1[H])O[H])=O)C([H])([H])[H])[C@]1([H])C([H])([H])C([H])([H])C([H])([H])N1C(C([H])([H])[C@]([H])([C@]([H])([C@@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])[H])N(C([H])([H])[H])C([C@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])N([H])C([C@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])N(C(=O)OC([H])([H])C1C([H])=C([H])C(=C([H])C=1[H])N([H])C([C@]([H])(C([H])([H])C([H])([H])C([H])([H])N([H])C(N([H])[H])=O)N([H])C([C@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])N([H])C(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])N1C(C([H])=C([H])C1=O)=O)=O)=O)=O)C([H])([H])[H])=O)=O)OC([H])([H])[H])=O